Despite the increase in cash burn, the company's solid cash runway and the analysts' forecast of reaching breakeven point suggest a positive outlook. The company's cash burn relative to its market capitalisation, which is US$1.4b, is about 1.7%, indicating that it could potentially raise more cash easily if needed.

Is it Nvidia, the maker of chips related to artificial intelligence? This is despite the fact that the stock has soared more than 200% this year. Other big tech stocks like Apple are up nearly 50% this year, Microsoft is up about 56%, Google parent Alphabet's Class A and Class C shares are up nearly 60% each, Amazon is up more than 80%, Tesla has doubled more than doubled, and Meta almost tripled.
However, none of these stoc...

The substantial share sale by President Anish Bhatnagar and the absence of insider purchases over the last year could signify uncertainty about the company's future. While insider ownership hints at certain alignment with shareholder interests, historical sales ignite cautiousness.

Insider selling of Soleno shares, particularly by Jack Schuler, may imply insiders see the shares as fully valued at lower prices. The insider ownership in Soleno Therapeutics isn't notably high, indicating perhaps a lack of insider belief in the company.